Abbott Laboratories
- Stock
- Ticker ABT
- ISIN US0028241000
- NYSE
Performance, volatility and drawdowns of Abbott Laboratories since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $31,255. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −39.6% in 05/2026, measured from the peak in 03/2025. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 10,974 | 10,358 | 11,142 | 11,369 | 11,459 | 11,164 | 12,593 | 13,013 |
| Gross profit | 6,032 | 5,890 | 6,288 | 6,294 | 6,537 | 6,274 | 7,268 | 7,385 |
| Operating income | 1,911 | 1,693 | 2,052 | 2,057 | 2,251 | 1,345 | 1,693 | 1,358 |
| EBITDA | 2,253 | 2,029 | 2,409 | 2,428 | 2,621 | 1,726 | 2,095 | 1,773 |
| Net income | 9,229 | 1,325 | 1,779 | 1,644 | 1,776 | 1,077 | 928 | 920 |
| Earnings per share | 5.26 | 0.76 | 1.01 | 0.94 | 1.02 | 0.61 | 0.53 | 0.53 |
| Balance sheet | ||||||||
| Total assets | 81,414 | 81,448 | 83,999 | 84,181 | 86,713 | 110,429 | 109,215 | 108,247 |
| Liabilities | 33,513 | 32,384 | 33,170 | 32,917 | 33,942 | 57,728 | 57,453 | 56,624 |
| Equity | 47,664 | 48,811 | 50,565 | 50,954 | 52,130 | 52,061 | 51,110 | 51,027 |
| Cash | 7,616 | 6,532 | 6,951 | 7,511 | 8,522 | 6,803 | 5,104 | 4,052 |
| Long-term debt | 12,625 | 12,736 | 12,930 | 11,596 | 9,896 | 29,638 | 29,603 | 29,451 |
| Cash flow | ||||||||
| Operating cash flow | 2,868 | 1,417 | 2,047 | 2,787 | 3,315 | 1,315 | 2,488 | 1,737 |
| Capital expenditure | -720 | -484 | -502 | -496 | -689 | -399 | -497 | -513 |
| Free cash flow | 2,148 | 933 | 1,545 | 2,291 | 2,626 | 916 | 1,991 | 1,224 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +52.0%, weakest 2022 at −20.7%. 8 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | $0.53 |
| 28 Jul 2026 | $0.53 |
| 29 Apr 2026 | $0.61 |
| 20 Feb 2026 | $1.02 |
| 29 Oct 2025 | $0.94 |
| 30 Jul 2025 | $1.01 |
| 30 Apr 2025 | $0.76 |
| 21 Feb 2025 | $5.26 |
| 31 Oct 2024 | $0.94 |
| 31 Jul 2024 | $0.74 |
| 2 May 2024 | $0.70 |
| 16 Feb 2024 | $0.91 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €162bn
- Market cap in trading currency
- $178bn
- Enterprise value
- $205bn
- P/E
- 38.3
- P/S
- 3.70
- P/B
- 3.50
- EV/Sales
- 4.26
- EV/EBITDA
- 25.0
- Earnings yield
- 2.6%
- FCF yield
- 3.8%
Results (last four quarters)
- Revenue
- $48.2bn
- Gross profit
- $27.5bn
- EBITDA
- $8.22bn
- Net income
- $4.70bn
- Earnings per share
- $2.69
- Revenue per share
- $27.85
- Revenue growth
- +14.5%
- Earnings growth
- −44.0%
Profitability
- Gross margin
- 56.9%
- Operating margin
- 13.8%
- Net margin
- 9.7%
- Return on equity
- 9.2%
- Return on assets
- 4.3%
Balance sheet and cash flow
- Cash
- $4.30bn
- Cash per share
- $2.48
- Financial debt
- $31.2bn
- Debt/equity %
- 61
- Current ratio
- 1.45
- Book value per share
- $29.46
- Operating cash flow
- $8.86bn
- Free cash flow
- $6.76bn
Dividend
- Dividend yield
- 2.45%
- Dividend (12 months)
- $2.52
- Yield (12 months)
- 2.45%
- Payout ratio
- 94%
- Ex-dividend date
- 15 Oct 2026
Shares and trading
- Shares outstanding
- 1.73bn
- Volume
- 7.10m
- Avg. volume 3 months
- 8.96m
- Relative volume
- 0.8
Price and technicals
- Price
- $103.00
- 1 day
- −0.8%
- 52-week high
- $128.90
- 52-week low
- $82.56
- Distance to 52-week high
- −20.1%
- Distance to 52-week low
- +24.8%
- Distance to 50-day line
- −0.9%
- Distance to 200-day line
- +1.5%
- RSI (14)
- 42
- Volatility 1M
- 32.5%
Performance
- 1 week
- −5.1%
- 1 month
- +0.5%
- 3 months
- −11.7%
- 6 months
- +17.8%
- YTD
- −17.8%
- 1 year
- −18.4%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ABT performed since 11/2016?
$10,000 grew to $31,255 by 20 Nov 2026, which is +12.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ABT?
Volatility was 21.1% per year, measured on monthly returns. The largest decline from a peak was −39.6%, with the low in 05/2026.
How does ABT compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ABT returned +12.1% at 21.1%. The correlation of monthly returns was 0.46; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.